|1.||Nguan, Christopher Y C: 2 articles (01/2015 - 03/2012)|
|2.||Guan, Qiunong: 2 articles (01/2015 - 03/2012)|
|3.||Du, Caigan: 2 articles (01/2015 - 03/2012)|
|4.||Yamaya, H: 2 articles (05/2014 - 01/2005)|
|5.||Franco-Gou, Rosa: 2 articles (07/2007 - 08/2006)|
|6.||Roselló-Catafau, Joan: 2 articles (07/2007 - 08/2006)|
|7.||Peralta, Carmen: 2 articles (07/2007 - 08/2006)|
|8.||Abdennebi, Hassen Ben: 2 articles (07/2007 - 08/2006)|
|9.||Ramella-Virieux, Silvina: 2 articles (08/2006 - 05/2005)|
|10.||Harvat, Tricia: 1 article (01/2015)|
06/01/1993 - "Prevention of CD18-mediated reperfusion injury enhances the efficacy of UW solution for 15-hr heart preservation."
10/01/2002 - "Livers cold preserved in University of Wisconsin (UW) solution followed by reperfusion suffer ischemia/reperfusion injuries. "
06/01/1990 - "These findings have defined some of the mechanisms of effectiveness of UW solution and suggest avenues of further exploration to improve simple hypothermic storage and to prevent reperfusion injury."
07/01/2007 - "The UW-PEG solution, while retaining all the advantages of UW solution, improved hepatic ischemia-reperfusion injury associated with liver transplantation."
08/01/1998 - "Primary liver graft dysfunction is currently related to cold ischemia-reperfusion injury, although a wide survival range has been reported using 24-hour preservation in cold University of Wisconsin (UW) solution. "
02/15/2007 - "As compared to other preservation solutions, University of Wisconsin (UW) solution was associated with significantly better outcome when ischemia exceeded 24 hr. Short ischemia did not eliminate the effect of HLA matching. "
10/01/2014 - "Biolasol solution protects kidneys against ischemia damage and does not differ significantly from the "golden standard" ViaSpan solution."
04/01/2013 - "However, a combination of SNO-HSA and UW solution can be used to prevent the two types of ischemia. "
04/01/2013 - "In contrast, SNO-HSA had no significant effect on warm liver ischemia injury which, however, can be reduced by UW solution. "
03/01/2007 - "Clinically, University of Wisconsin (UW) solution for organ preservation is still the major milestone for prevention of ischemia- and reperfusion-associated injury. "
06/01/2000 - "Though the UW solution prevented myocardial cellular edema, subendocardial perfusion was incomplete and the recovery rate of myocardial HEP levels was lower, suggesting that diluted blood may become the solution of choice as a perfusate."
04/15/1996 - "We conclude that macromolecules limit edema formation, but other constituents of UW solution limit edema formation also."
01/01/1995 - "Clinically, only in the University of Wisconsin (UW) solution oncotic substances for the prevention of cellular edema are used. "
06/01/1994 - "The beneficial effect of UW solution may result from its ability to prevent tissue edema during cold storage. "
12/01/2013 - "Although HTK solution shows conflicting results with respect to pancreatic cellular edema, researchers in several studies have noted that HTK solution may be more protective than UW solution against biliary complications in liver transplant. "
|4.||Delayed Graft Function
04/01/1994 - "The second set of data consisted of all the kidneys preserved in UW solution (n = 62) at our institution and of 57 kidneys preserved by hypothermic continuous pulsatile perfusion during the same period (mixed data) and was used to evaluate the effect of prolonged preservation (longer than 24 hours) on delayed graft function. "
07/18/1992 - "The preservation solution is the most important factor influencing development of delayed graft function, and UW solution is superior to EuroCollins solution in reducing occurrence of delayed graft function, improving graft function, extending graft survival."
08/01/2003 - "To determine whether Belzer solution (Viaspan, Bristol-Myers Squibb, Brussels, Belgium), which is more expensive than Eurocollins solution, was better at preventing delayed graft function (DGF) and whether it was cost-effective as it could potentially reduce post-transplantation complications. "
01/01/1995 - "We feel that the use of UW solution for pancreas preservation has contributed to improved pancreas graft survival and has reduced early graft thrombosis despite much longer cold ischemia times of over 12 h. "
04/01/2002 - "Post-transplantation thrombosis may occur in donor segments of iliac arteries and livers following surgical removal and storage in University of Wisconsin (UW) solution for transplantation. "
03/01/1996 - "In summary, the impaired endothelium-dependent relaxation by UW solution and prominent endothelium-dependent contraction to hypoxia of human hepatic artery would favor vasospasm and thrombus formation after liver transplantation."
|3.||Endothelin A Receptor
|5.||Bretschneider cardioplegic solution
|3.||Transplantation (Transplant Recipients)